EXCELSIOR MEDICAL CO., LTD.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Private
- Established
- 2019-08-01
- Employees
- 11
- Market Cap
- -
- Website
- https://excelsior.one
A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
Not yet recruiting
- Conditions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Excelsior
- Target Recruit Count
- 20
- Registration Number
- NCT06603285
A Study of Oral EX039 in Subjects With Mild Alzheimer's Disease
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Excelsior
- Target Recruit Count
- 120
- Registration Number
- NCT05413655
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients
Completed
- Conditions
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- Excelsior
- Target Recruit Count
- 48
- Registration Number
- NCT03299829
- Locations
- 🇨🇳
Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan
An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Excelsior
- Target Recruit Count
- 253
- Registration Number
- NCT01725646
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
© Copyright 2024. All Rights Reserved by MedPath